AbbVie Limited — China drug registrations and re-registration deadlines
10 certificates in the NMPA overseas-manufactured drug database (境外生产药品库), snapshot 2026-06-28. Earliest re-registration deadline: 2026-12-13.
| Approval number | Product | Certificate expires | Re-registration deadline (Art. 82) |
|---|---|---|---|
| 国药准字SJ20171003 | BOTOX 注射用A型肉毒毒素 | 2027-06-13 | 2026-12-13 |
| 国药准字SJ20171004 | BOTOX 注射用A型肉毒毒素 | 2027-06-13 | 2026-12-13 |
| 国药准字SJ20171005 | BOTOX 注射用A型肉毒毒素 | 2027-06-13 | 2026-12-13 |
| 国药准字HJ20171243 | Pred Forte 醋酸泼尼松龙滴眼液 | 2027-11-03 | 2027-05-03 |
| 国药准字HJ20171244 | Pred Forte 醋酸泼尼松龙滴眼液 | 2027-11-03 | 2027-05-03 |
| 国药准字HJ20130754 | FML 氟米龙滴眼液 | 2028-08-28 | 2028-02-28 |
| 国药准字HJ20140945 | Carboxymethylcellulose Sodium Eye Drops 羧甲基纤维素钠滴眼液 | 2029-08-25 | 2029-02-25 |
| 国药准字HJ20140946 | Refresh Celluvisc 羧甲基纤维素钠滴眼液 | 2029-08-25 | 2029-02-25 |
| 国药准字HJ20140928 | Brimonidine Tartrate and Timolol Maleate Eye Drops 溴莫尼定噻吗洛尔滴眼液 | 2029-10-28 | 2029-04-28 |
| 国药准字HJ20160681 | ALPHAGAN 酒石酸溴莫尼定滴眼液 | 2031-04-27 | 2030-10-27 |
Under the Provisions for Drug Registration (药品注册管理办法) Art. 82, an application to renew an overseas-manufactured drug registration is filed with the Center for Drug Evaluation no later than 6 months before the certificate expires; the filing line column is that arithmetic applied to the expiry cell. Art. 84(1): a certificate with no application by expiry is not re-registered and is cancelled at expiry. Every figure is taken from the public NMPA database as of 2026-06-28, or computed from it. Registration data changes; the NMPA portal governs. This page states no view on whether any of these products' Domestic Responsible Person (境内责任人) arrangements meet NMPA Announcement No. 137 — that cannot be determined from a public entry.